Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis

<status value="draft"/><description value="Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis"/><relatedArtifact><type value="citation"/><label value="Emberson 2014"/><display value="Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials."/><citation value="Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063"/><document><url value="https://doi.org/10.1016/S0140-6736(14)60584-5"/></document></relatedArtifact><relatedArtifact><type value="citation"/><label value="Lees 2016"/><display value="Figure 2 Lees 2016"/><citation value="Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016;47:2373-2379. PMID 27507856"/><document><url value="https://doi.org/10.1161/STROKEAHA.116.013644"/></document></relatedArtifact><actual value="true"/><characteristic><description value="Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis"/><definitionByCombination><code value="any-of"/><characteristic><definitionReference><reference value="Group/ECASSIII-Trial-Cohort"/><type value="Group"/><display value="ECASS III Trial Cohort"/></definitionReference></characteristic><characteristic><definitionReference><reference value="Group/IST3-Trial-Cohort"/><type value="Group"/><display value="IST3 Trial Cohort"/></definitionReference></characteristic><characteristic><definitionReference><reference value="Group/ECASS-Trial-Cohort"/><type value="Group"/><display value="ECASS Trial Cohort"/></definitionReference></characteristic><characteristic><definitionReference><reference value="Group/ECASSII-Trial-Cohort"/><type value="Group"/><display value="ECASSII Trial Cohort"/></definitionReference></characteristic><characteristic><definitionReference><reference value="Group/EPITHET-Trial-Cohort"/><type value="Group"/><display value="EPITHET Trial Cohort"/></definitionReference></characteristic><characteristic><definitionReference><reference value="Group/ATLANTIS-Trial-Cohort"/><type value="Group"/><display value="ATLANTIS Trial Cohort"/></definitionReference></characteristic><characteristic><definitionReference><reference value="Group/NINDS-Trial-Cohort"/><type value="Group"/><display value="NINDS Trial Cohort"/></definitionReference></characteristic></definitionByCombination></characteristic></EvidenceVariable>